INTRODUCTION
Analyses of DNA from ancient and degraded samples and fossils are hindered by problems caused by the nature of the studied substrate; that is, the molecules are present at very low copy number, are fragmented, and contain modified bases. PCR amplification has made it possible to analyze genetic information from such material, but amplification of the degraded and modified DNA is not very efficient and sporadically contaminating intact modern DNA molecules can be preferentially amplified (1) . Indeed, this contamination caused erroneous results (2, 3) . Furthermore, base modifications cause base substitution during PCR amplification, leading to erroneous sequence information (1, (4) (5) (6) . These drawbacks led to the establishment of criteria to increase the likelihood of the authenticity of ancient DNA sequences (7) . In particular, it is necessary to set up experimental conditions that prevent as nearly as possible any contamination by modern DNA and to clone PCRamplified DNA to obtain sequence information from independent original molecules, to assess sequence heterogeneity, and to track possible base misincorporations (7, 8) .
There are four major sources of contamination by modern DNA: (i) the environment and the experimenters (archeologists, biologists, etc.); (ii) other ancient specimens; (iii) previous PCR products; and (iv) plasmids with the cloned target sequence. The latter two sources of contamination are usually controlled by physical containment. Nevertheless, they remain a major threat due to the high number of contaminating molecules. PCR itself produces in just one reaction up to 10 11 copies of the ancient target sequence. These molecules are easily spread via aerosol transport. One aerosol droplet can contain many more DNA molecules than one gram of fossil material. Cloning is the second source of contamination because 10 11 molecules containing the target sequence are produced in just one milliliter of bacterial culture. These contamination sources are common to all research areas that analyze degraded DNA in very small amounts [e.g., paleogenetics, forensic and conservation genetics, certain areas of medical research, and DNA traceability (analysis of DNA traces in food, soil etc.)]. The susceptibility to contamination increases with decreasing numbers of amplifiable target molecules.
Contamination with substantial amounts of DNA can be identified quite easily by running negative controls during the PCR, but lowlevel contamination leading to PCR amplification in only a few percent of the samples is more covert because it occurs with a frequency similar to bona fide amplification from ancient material and can be easily missed in conventional PCR assays when one is running only a few negative controls (8, 9) . Furthermore, contamination with previously amplified material can severely compromise the demonstrative value of data replication, even when performed in different laboratories. In many cases, these exchange material and may thus exchange contaminants as well. Rigorous practices in ancient or forensic DNA analyses should keep contamination to a low level that cannot seriously be guaranteed to be zero.
Quantitative real-time PCR (QPCR) is a useful quality control, which allows the quantification of both the target molecules in the extracts (10) (11) (12) and the inhibition by products contained in all fossil extracts (10) . Procedures that lower the risk of contamination with amplified or cloned products, but are still compatible with both QPCR and specific requirements for ancient DNA studies, would further increase the reliability of the analyses.
Degradation of carryover contaminating molecules prior to amplification with various enzymes has been proposed. A current procedure makes use of dUTP incorporation instead of dTTP during amplification, which is preceded by treatment with a heatlabile uracil-N-glycosylase (UNG) to degrade uridine-containing carryover products from previous PCR amplifications (13 SHORT TECHNICAL REPORTS UPCR. Even though UNG treatment is sometimes used to remove deaminated cytosine residues from ancient DNA samples prior to amplification to minimize nucleotide misincorporation (4, 14) , UPCR is not in current practice in the ancient DNA field. Indeed, several issues limit its usefulness: (i) because ancient DNA is highly degraded, only small PCR fragments can be amplified, but it is unclear whether the current UPCR procedures are efficient enough to provide significant protection from carryover contamination in this type of setting (15); (ii) because "jumping PCR" between small fragments has been shown to cause nucleotide misincorporation and in vitro recombination, leading to sequence chimerism (1, 6) , it would be dangerous to favor jumping PCR events between subfragments of previously amplified PCR products that could be artifactually distinct from the known products and thus erroneously considered as authentic and novel; (iii) the desired cloning of the PCR products cannot be performed in current Escherichia coli strains used for cloning purposes because they degrade uridine-containing DNA.
Here we address the issue of enzymatic degradation of carryover contamination in ancient DNA research. We show that UQPCR, that is, the coupling of UPCR and QPCR, and DNA cloning in an E. coli strain deficient in both UNG and dUTPase activities provide a satisfying level of contamination prevention that meets the specific requirements of ancient DNA analyses.
MATERIALS AND METHODS

DNA Extraction from Fossil Material
DNA extraction was carried out as previously described (10) . For details, please see the supplemental data that is available on the BioTechniques' web site at www.BioTechniques.com.
Quantitative Real-Time PCR
A 103-bp fragment of the tetracycline gene of the plasmid pBR322 was amplified using primers BR1 (5′-ATGCGTTGATGCAATTCT-3′) and BR2 (5′-GTCGATAGTGGCT-CCAAGTA-3′). The sequence of the resulting fragment is 5′-ATGCGTT-
The primers used for the analysis of ancient bovine mitochondrial DNA amplify a 153-bp product from nucleotides 16,022-16,175 of the D-loop (BB3, 5′-GCCCCATGCATATA-AGAAGT-3′ and BB4, 5′-GCGGCAT-GGTAATTAAGCTC-3′).
Amplifications were carried out in the LightCycler™ (Roche Applied Science, Penzberg, Germany) in individual glass capillaries using a modified version of the Platinum ® Quantitative PCR SuperMix-UDG (Invitrogen, Carlsbad, CA, USA) in a total volume of 20 µL. The final composition was 10 mM Tris-HCl, pH 8.0, 50 mM KCl, 4.5 mM MgCl 2 , 400 µM dUTP, 200 µM dATP, 200 µM dCTP, 200 µM dGTP, 0.4 U UNG, 0.6 U Platinum Taq DNA polymerase (part of the kit); proprietary stabilizers (part of the kit); 4% glycerol; 100 µg/mL of either bovine serum albumin (BSA; Sigma, St. Louis, MO, USA) or, in the case of bovine fossils, horse albumin (globulin-free Horse Serum Albumin; Sigma); 0.05% polyoxyethylene ether W1 (Sigma); 1/10.000 SYBR ® Green I (Molecular Probes, Leiden, The Netherlands) supplemented with 10 pmol of each primer per reaction; and additional 0.8 U Platinum Taq DNA polymerase. The cycling program was as follows: 45 min at 37°C, 2 min at 95°C, and 50 cycles of 5 s at 95°C, 10 s at 58°C or 60°C (for pBR and BB34, respectively), and 12 s at 72°C.
Cloning of the PCR Products
The PCR products were cloned using the pGEM ® -T Easy Vector System kit (Promega, Madison, WI, USA), according to the manufacturer's protocol. Transformation of the dut, ung E. coli strain RZ1032 (16) was carried out by electroporation in a Gene Pulser ® (Bio-Rad Laboratories, Hercules, CA, USA), following the manufacturer's protocol.
RESULTS AND DISCUSSION
QPCR Amplification Using dUTP and Degradation by UNG
We have adapted UNG-coupled quantitative real-time PCR (UQPCR) to the analysis of ancient DNA. This included the assessment and improvement of the efficiencies of both PCR amplification and degradation of carryover contamination to meet the specific requirements of ancient DNA studies.
The replacement of dTTP by dUTP lowers the PCR efficiency (17) . Cumulative decrease in efficiency is a major concern with samples containing damaged DNA and inhibitors. We improved a commercially available dUTP-and SYBR Green I-containing QPCR mixture (Platinum Quantitative PCR SuperMix-UDG) by supplementing it with detergents, serum albumin, and extra Taq DNA polymerase. This allowed us to achieve 90% to 100% efficiency of PCR amplification with numerous primers using the Light Cycler. A critical parameter for any DNA amplification starting from a low number of molecules is the sensitivity of the reaction. To test whether the sensitivity of UQPCR is decreased due to the replacement of dUTP by dTTP, we compared PCRs performed with either dUTP or dTTP and very low levels of template molecules (i.e., statistically about one template molecule per reaction). Amplification occurred in 9 PCRs of 18 when dTTP was used and in 10 of 18 when dUTP was used (data not shown). This shows that the use of dUTP in the conditions described here does not affect the sensitivity of the PCR.
We then elaborated conditions for UNG treatment providing sufficient carryover protection even when a short PCR fragment is amplified (103 bp including the primers) because such short fragments can often be amplified from severely degraded ancient DNA when longer fragments cannot. We used as a critical test for the efficiency of the carryover protection a short (103 bp) fragment with a relatively low AT content (41%), thus incorporating a low level of dUTP. This fragment originates from the tetracycline resistance gene in pBR322, which is absent from most modern cloning vectors and is therefore relatively insensitive to the contaminants commonly found in a conventional molecular biology laboratory. Furthermore, this assay does not present a contamination risk of its own for ancient DNA analyses.
We tested several commercially available QPCR mixtures that either contained UNG or were supplemented with UNG from various sources. We observed that most of them provided an unreliable level of protection from carryover contamination when small fragments (≤100 bp) were amplified because they retarded the amplification of dU-containing PCR products by only 5-8 cycles (data not shown). This is in agreement with previously published studies reporting that the UPCR procedure offers satisfactory carryover protection for longer fragments only [>240 bp (13) ; generally 1 kb (18)]. We observed, however, that the addition of stabilizers and a longer incubation time for the UNG treatment provided a much higher level of carryover protection (Figure 1 ). In particular, we noticed lotto-lot variability that could be leveled out by modulating the length of the UNG incubation step. Increasing the UNG digestion time from 5 min (the manufacturer's recommended time) to 45 min led to satisfactory levels of carryover protection (at 37°C; Figure  1A ). The UNG treatment retarded the amplification from 7 cycles (5 min incubation) to 14.9 cycles (45 min incubation). Thus, in this experiment, the longer UNG incubation step improved, at no further expense, the level of protection by two orders of magnitude: the remaining, amplifiable material was decreased from 1.3% to 0.012% ± 0.005% of the initial material. This remaining material, corresponding to dU-containing fragments, was not fully degraded, as quantified by gel analysis (see Supplementary Figure S1 ). Supplementation with additional UNG from various commercial sources did not provide an equivalent level of protection but increased the costs considerably (data not shown). We have used these conditions over a period of two years and observed significant lot-to-lot variations in the efficiency of carryover protection. We therefore regularly test the reagents directly in our UQPCR mixture with a titration curve of dT-or dU-containing fragments. In the experiment shown in Figure 1B , after a 15-min incubation, the amplification efficiency was 96% ± 2% and the ΔCp (Cp, the number of cycles required to reach a threshold level of fluorescence in the log phase of the amplification) between the dT and the dU-containing template was 12.6% ± 0.3% cycles, corresponding to the amplification of 0.021% ± 0.006% of the initial dU-template. Here carryover protection was relatively insensitive to variations in incubation times (see Supplementary Figure S1 , panel B). Thus, in this reaction mixture, the activity and the amount of UNG were high enough to render a longer incubation step unnecessary, showing that the remaining amplifiable material did not result from incomplete UNG degradation. We further tested whether the degradation of the abasic sites could be a limiting factor by varying the length of the 95°C post-UNG incubation step. When this step was extended from 2 to 10 min, the amplification efficiency decreased from 96% to 90% (see Supplementary Figure S1, panel B) . Even though the ΔCp between dT-and dU-containing fragments is larger, this does not correspond to a higher level of protection when the lowered amplification efficiency is taken into account. Thus, no additional protection was achieved by varying this parameter.
Fidelity of UQPCR
What could be the nature of the remaining material amplified from UNG-treated dU template when prolonged UNG treatment does not afford extra protection? If it contained remaining abasic sites, they should not stop DNA polymerization because Taq DNA polymerases are able to perform bypass synthesis across this lesion (19) . Alternatively, amplifiable material could be reconstituted from the fragmented template molecules in the early steps of the PCR by jumping PCR. Both bypass polymerization and jumping PCR are a major source of base misincorporation with the potential to (A) Quantification by QPCR of the amount of material that can be amplified following various uracil-Nglycosylase (UNG) treatments. A PCR product (pBR12) amplified from plasmid pBR322 using dUTP (pBR12U) was incubated in the UNG-containing PCR mixtures for the indicated time at 37°C, and the reactions were then incubated at 95°C for 2 min. Ten-fold serial dilutions were then amplified in a LightCycler using primers BR1 and BR2 and SYBR Green I-containing QPCR mixtures devoid of UNG. On the ordinate, the relative amount of input material in the log scale is represented; on the abscissa, the number of cycles required to reach a threshold level of fluorescence in the log phase of the amplification (Cp) is represented. The slope of the line allows for the calculation of the amplification efficiency using the formula 1 + E = 10 -1/slope (here 83%), while the number of cycles separating each line (ΔCp) allows for the deduction of the relative amount of material amplified from the various UNG reactions. (B) Simultaneous QPCR analyses of the amplification of a dU-and a dT-containing PCR fragment using an UNG-containing QPCR mixture. We used ten-fold serial dilutions of a solution containing identical amounts of PCR fragments amplified in the presence of either dUTP (pBR12U) or dTTP (pBR12T). The relative fragment amounts do not correspond to those shown in Figure 1A , but the data are represented in the same manner. The UNG incubation step was 15 min at 37°C, and the denaturation/strand scission step lasted for 2 min at 95°C, directly followed by QPCR amplification (PCR efficiency 96% ± 2%). UQPCR, uracil-N-glycosylase treatment plus quantitative PCR; QPCR, quantitative real-time PCR.
give rise to in vitro mutations (6, 20) . In ancient DNA analyses, modification of the DNA sequence of previously amplified PCR products would render the UQPCR approach worse than a lack of decontamination.
Indeed, when the DNA sequence of the PCR product from a newly analyzed sample is identical to one that had been previously obtained in the laboratory, suspicions of carryover contamination are legitimate. However, if the novel sequences differ from those previously obtained, carryover contamination is unlikely unless the procedure for carryover protection is itself mutagenic. This prompted us to analyze whether the sequences of the molecules amplified from an UNG-treated dU-containing DNA fragment were identical to the starting sequence. Eleven clones of the PCR product were sequenced and not a single base modification was detected. This is not entirely surprising because the most common misincorporation that results from both bypass synthesis and jumping PCR should not cause sequence variation when abasic sites and strand breaks are produced at dU nucleotides. Regardless of the type of DNA polymerase used, the nucleotide that is most frequently incorporated in front of an abasic site is dA because it fits best in front of the gapped strand (20) . Furthermore, when Taq DNA polymerases add a nontemplated nucleotide, this latter is also a dA (20) . Thus, in most cases, a dA should be inserted in front of the position where a dU was formerly located, just as it would if the dU were intact.
Inhibition of UQPCR by Fossil Extracts
Extracts of ancient tissues usually contain noncharacterized Taq DNA polymerase inhibitors. These could potentially inhibit the UNG, too, thus lowering the usefulness of the carryover protection. We therefore tested the inhibitory effect of fossil extracts on UQPCR. To do so, dU-and dT-containing pBR fragments were amplified by UQPCR in the presence of extracts from different fossil bones (Figure 2 ): one extract from an approximately 3000-year-old aurochs (extract A) and one extract from an approximately 3000-year-old deer bone (extract B) that showed different levels of inhibition of the PCR. When the amount of fossil extract used did not inhibit the PCR, it did not modify the protective effect of UNG either ( Figure  2, extract A) . When the amount of fossil extract used moderately decreased the PCR efficiency, dT-and dU-containing templates were affected similarly. The ΔCp separating the amplification of these templates was not modified by the fossil extracts. Because the amplification efficiency decreased, the ΔCp should have been increased if UNG was insensitive to inhibition. Thus, fossil extract B inhibited the UNG, but not more than the Taq DNA polymerase. The protective effect achieved by UQPCR was preserved. 
Ancient DNA Amplification Using UQPCR
Deaminated cytosines have been described as the major class of lesions in ancient DNA (4) . These modified bases are a substrate of the UNG, ultimately resulting in fragmentation of the corresponding DNA molecules during PCR. Thus, UQPCR could be detrimental to fossil DNA containing several deaminated cytosines per molecule. Nevertheless, deaminated cytosines are also a major source of nucleotide misincorporation and thus of erroneous data (4). UNG treatment corrects those errors and therefore increases the reliability of the analysis (4). We assessed by QPCR the impact of UNG treatment on the amplification of fossil extracts from 10 samples that we had previously analyzed by UQPCR. The amplification products of three of them were authenticated by sequence analysis, the other seven yielded amplification products only rarely. In the case of the three extracts containing relatively high amounts of DNA, we did not observe any significant differences between the amplifications regardless of whether or not they were preceded by UNG treatment (Table 1 ). In the case of the seven extracts that were rarely amplified, amplification was no better when we omitted UNG. UNG treatment was therefore not responsible for the loss of amplifiable material with these fossils.
With some fossil extracts, it was previously described that UNG treatment was not responsible for the loss of amplifiable material (5) . In contrast, with other extracts, it was shown that UNG treatment allowed for the correction of most sequence errors, but no information was provided about a possible decrease in the amount of amplifiable material (4) . Nevertheless, it is conceivable that some ancient extracts contain only few molecules with a high content of deaminated cytosines, which will be fully degraded by UNG, thus preventing their amplification. The amplified, cloned, and sequenced PCR products from such badly damaged DNA, however, are likely to contain numerous sequence errors when not treated with UNG. Deduction of the correct sequence would thus require multiple repetitions of amplification and sequencing. Therefore, the information lost when UQPCR is used might not be reliable enough for its loss to be a serious drawback.
Cloning of dU-Containing PCR Products
In ancient DNA analyses, PCR products have to be amenable to DNA cloning, which, in most E. coli strains, is not the case for dU-containing DNA. To circumvent this and to extend the usefulness of UQPCR for the prevention of contamination by cloned DNA, which is another major source of contamination, we used as a cloning recipient an E. coli strain mutated in both the UNG and the dUTPase genes. In such instances, up to 20% of thymine is replaced by uracil (21) . This renders cloned DNA sensitive to UNG cleavage in vitro and thus provides protection from carryover contamination with cloned material. Because the cloned template contains 5-fold less dU than the corresponding PCR products, carryover protection is not as efficient. In our QPCR analyses with the previously described primer pair, amplifications after an optimal UNG treatment of plasmid pBR322 extracted from a Dut -Ung -strain were retarded by 4.2 cycles when compared to plasmid DNA extracted from a wild-type strain. This corresponds to a 94% reduction in the amount of amplifiable material. Thus, the level of carryover protection for plasmid DNA is not as high as for PCR products. However, because it is not necessary to systematically clone UQPCR products and because the concentration of amplifiable molecules in bacterial cultures is about 10-fold lower than in PCR, this cloning system contributes considerably to the safety of ancient DNA analyses. Moreover, possible contamination by plasmid DNA can easily be identified using PCR primers hybridizing within the plasmid backbone. Thus, when the sequence of a PCR product corresponds to a plasmid that was present in the laboratory, it is worthwhile to perform this simple control.
Conclusion
We have shown here that several adaptations of the classical application of dUTP and UNG in PCR amplification can provide significant protection from carryover contamination and meet the special requirements of ancient DNA analyses. The use of a Dut -Ung -E. coli strain simultaneously allows for the cloning of dU-containing PCR products and provides substantial protection from carryover contamination with plasmid DNA. We show that the UNG treatment is not responsible for an increase in nucleotide misincorporation. Therefore, there is no increased risk of erroneous attribution of sequence differences stemming from previously amplified DNA to bona fide ancient DNA. Finally, we have used UQPCR with fossil extracts to show that its protective effect is preserved even when the extract contains inhibitors decreasing the efficiency of the PCR. We have not observed the presence of inhibitors acting on UNG preferentially without affecting amplification. Furthermore, with several fossil extracts containing amplifiable material that could be unambiguously identified by nucleotide sequence, we have not observed sequence errors in amplification products from UNG treated templates. This might be due to the fact that UNG removes deaminated cytosines, the major source of sequence errors in ancient DNA amplification (4) .
Thus, UQPCR increases the reliability of the sequence data obtained from samples containing very low numbers of template DNA molecules, which is the case in forensics and in studies of wild life, ancient DNA, and DNA tracing.
